cutaquig
(Immunoglobulin G)Pfizer Laboratories Div Pfizer Inc
Usage: Cutaquig is a subcutaneous immune globulin solution indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years and older, including CVID, X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.